The Essential Ingredients for Pushing Precision Medicine Forward
Mary Zutter, MD, to share Vanderbilt’s lessons learned in assembling resources, selecting disease targets, and engaging physicians in precision medicine pursuits…
Mary Zutter, MD, to share Vanderbilt’s lessons learned in assembling resources, selecting disease targets, and engaging physicians in precision medicine pursuits…
Olivier Elemento, PhD, to share what whole exome sequencing, whole genome sequencing, and artificial intelligence will mean to medicine and patient care…
Phil Febbo, MD, CMO of sequencing company Illumina, to discuss what company is doing to make it easier for health systems to adopt next-generation sequencing…
Mayo Clinic professor Richard Weinshilboum, MD, describes a near future in which preemptive gene sequencing becomes standard of care for safe and effective drug therapies…
It’s been a little more than a year since Geisinger launched its National Precision Health Initiative, a first-of-its kind unit designed to advance the promise of anticipatory medicine at Geisinger and at healthcare systems throughout the United States…
Rapidly falling costs and the increasing clinical value of human genome sequencing and genetic testing is reaching the point where innovative hospitals and health networks are ready to offer these services to patients in family practice settings…
Prominent health networks/hospitals participate in NIH genetic research supported by more than one billion dollars in funding from the federal government…
Ongoing growth in consumer genetic testing pressures hospitals and healthcare networks to educate and prepare their primary care physicians for informed patients…
Syapse of San Francisco has created a precision medicine council that quickly attracted 200 of the biggest hospitals and health networks as members…
Hospitals and healthcare systems increasingly using genomic profiling must integrate it into all facets of care delivery, not just add it to patients’ EHRs…